57280 Federal Register / Vol. 75, No. 181 / Monday, September 20, 2010 / Notices 

Date and Time: The meeting will be 

held on November 8, 2010, from 8 a.m. 

to 5 p.m. and November 9, 2010, from 

8 a.m. to 2 p.m. 

Location: FDA White Oak Campus, 

Building 31 Conference Center, Great 

Room, 10903 New Hampshire Ave., 

Silver Spring, MD 20993. Please note 

visitors can park in the southwest garage 

near Building 31 or the northwest 

parking lot near Building 22 (for a 

campus map, see http://www.fda.gov/ 

downloads/AboutFDA/WorkingatFDA/ 

BuildingsandFacilities/WhiteOak

CampusInformation/UCM194893.pdf). 

Visitors to the White Oak Campus must 

have a valid driver’s license or other 

picture ID, and must enter through 

Building 1. 

Contact Person: Lee L. Zwanziger, 

Office of Policy, Planning and 

Preparedness, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 32, rm. 3278, Silver Spring, 

MD, 20993, 301–796–9151, FAX: 301– 

847–8611, e-mail: RCAC@fda.hhs.gov, 

or FDA Advisory Committee 

Information Line, 1–800–741–8138 

(301–443–0572 in the Washington, DC 

area), code 8732112560. Please call the 

Information Line for up-to-date 

information on this meeting. A notice in 

the Federal Register about last minute 

modifications that impact a previously 

announced advisory committee meeting 

cannot always be published quickly 

enough to provide timely notice. 

Therefore, you should always check the 

agency’s Web site and call the 

appropriate advisory committee hot 

line/phone line to learn about possible 

modifications before coming to the 

meeting. 

Agenda: On November 8 and 9, 2010, 

the Committee will hear and discuss 

developments in FDA’s ongoing 

communications programs, such as 

FDA’s Strategic Plan for Risk 

Communication, FDA’s Transparency 

Initiative, and the challenges of 

effectively communicating with patients 

and caregivers about appropriate use of 

medical devices when a patient is 

prescribed a medical device for home 

use. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before October 29, 2010. 

Oral presentations from the public will 

be scheduled between approximately 1 

p.m. and 2 p.m. on November 8, 2010, 

and 10:30 to 11:30 a.m. on November 9, 

2010. Those desiring to make formal 

oral presentations should notify the 

contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before October 21, 2010. Time 

allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled open public hearing session, 

FDA may conduct a lottery to determine 

the speakers for the scheduled open 

public hearing session. The contact 

person will notify interested persons 

regarding their request to speak by 

October 22, 2010. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Lee 

Zwanziger at least 7 days in advance of 

the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/ 

AdvisoryCommittees/AboutAdvisory

Committees/ucm111462.htm for 

procedures on public conduct during 

advisory committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: September 14, 2010. 

Jill Hartzler Warner, 

Acting Associate Commissioner for Special 

Medical Programs. 

[FR Doc. 2010–23368 Filed 9–17–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIEHS. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

NATIONAL INSTITUTE OF 

ENVIRONMENTAL HEALTH 

SCIENCES, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, NIEHS. 

Date: October 17–19, 2010. 

Closed: October 17, 2010, 7 p.m. to 10 p.m 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Doubletree Guest Suites, 2515 

Meridian Parkway, Research Triangle Park, 

NC 27713. 

Open: October 18, 2010, 8:30 a.m. to 11:50 

a.m. 

Agenda: An overview of the organization 

and research in the Laboratory of 

Reproductive and Developmental 

Toxicology. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Closed: October 18, 2010, 11:50 a.m. to 

12:35 p.m. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Open: October 18, 2010, 1:30 p.m. to 2:45 

p.m. 

Agenda: An overview of the organization 

and research in the Laboratory of 

Reproductive and Developmental 

Toxicology. 


jdjones on DSK8KYBLC1PROD with NOTICES
Federal Register / Vol. 75, No. 181 / Monday, September 20, 2010 / Notices 57281 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Closed: October 18, 2010, 2:45 p.m. to 3 

p.m. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Open: October 18, 2010, 3:15 p.m. to 4:30 

p.m. 

Agenda: Scientific Presentations. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Closed: October 18, 2010, 4:30 p.m. to 5:30 

p.m. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Closed: October 18, 2010, 7:30 p.m. to 

Adjournment. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Doubletree Guest Suites, 2515 

Meridian Parkway, Research Triangle Park, 

NC 27713. 

Closed: October 19, 2010, 8:30 a.m. to 10 

a.m. 

Agenda: To review and evaluate 

programmatic and personnel issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T. W. Alexander Drive, Conference 

Rooms 101 A, B, and C, Research Triangle 

Park, NC 27709. 

Contact Person: William T Schrader, PhD, 

Deputy Scientific Director, Office of the 

Scientific Director, National Institute of 

Environmental Health Sciences, 111 T.W. 

Alexander Drive, Research Triangle Park, NC 

27709, (919) 541–3433, 

schrader@niehs.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: September 9, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23382 Filed 9–17–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 11 a.m.–2 p.m., October 7, 

2010. 

Place: Audio Conference Call via FTS 

Conferencing. The USA toll-free, dial-in 

number is 1(866) 659–0537 and the pass code 

is 9933701. 

Status: Open to the public, but without a 

public comment period. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

Act of 2000 to advise the President on a 

variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines, which 

have been promulgated by the Department of 

Health and Human Services (HHS) as a final 

rule; advice on methods of dose 

reconstruction, which have also been 

promulgated by HHS as a final rule; advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). 

In December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, which 

subsequently delegated this authority to the 

CDC. NIOSH implements this responsibility 

for CDC. The charter was issued on August 

3, 2001, renewed at appropriate intervals and 

will expire on August 3, 2011. 

Purpose: This Advisory Board is charged 

with (a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. 

Matters to be Discussed: The agenda for the 

conference call includes: NIOSH 10-Year 

Review of its Division of Compensation 

Analysis and Support (DCAS) Program; 

Review of Public Comments to the Advisory 

Board during May 2010 Meeting; Status of 

DOL Policy Issuance on Use of Ruttenber 

Data; Coordinating DCAS Support of Board 

Activities; Advisory Board Subcommittee 

and Work Group Updates; and, DCAS SEC 

Petition Evaluations Update for the 

November 2010 Advisory Board Meeting. 

The agenda is subject to change as 

priorities dictate. 

Because there is not a public comment 

period, written comments may be submitted. 

Any written comments received will be 

included in the official record of the meeting 

and should be submitted to the contact 

person below in advance of the meeting. 

Contact Person for More Information: 

Theodore M. Katz, M.P.A., Executive 

Secretary, NIOSH, CDC, 1600 Clifton Road 

NE., Mailstop: E–20, Atlanta, GA 30333, 

Telephone (513) 533–6800, Toll Free 1(800) 

CDC–INFO, E-mail ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 14, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–23378 Filed 9–17–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary delisting 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS 

ACTION: Notice of Delisting. 

SUMMARY: AHRQ has accepted a 

notification of voluntary relinquishment 

from the Florida Patient Safety 

Corporation of its status as a Patient 

Safety Organization (PSO). The Patient 

Safety and Quality Improvement Act of 

2005 (Patient Safety Act), Public Law 

109–41, 42 U.S.C. 299b–21—b–26, 

provides for the formation of PSOs, 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 


jdjones on DSK8KYBLC1PROD with NOTICES